We describe and discuss the most recent findings on the activity and function of the oligomeric AAA+ chaperone ClpB from the Hsp100 protein family in pathogenic microorganisms. Pathogens are exposed to significant stress during infection of the host cells, frequently resulting in protein aggregation. The fact that ClpB is usually up-regulated in pathogens together with its immune reactivity suggests that ClpB acting as a protein disaggregase may be important for pathogen invasion and virulence. However, the specific function of ClpB in pathogenicity is still unclear. Since it is known that ClpB does not exist in mammals, it may serve as a potential target for the development of an effective therapy against several major bacterial diseases that do not respond to conventional antibiotics.
INTRODUCTION

ClpB, an AAA+ ATPase Chaperone
Bacterial molecular chaperone ClpB solubilizes and reactivates stress-agregated proteins in collaboration with the DnaK chaperone system by forming a bichaperone network that is crucial for the development of bacterial thermotolerance [1, 2] . Yeast proteins Hsp104 (located in the cytosol) and Hsp78 (found in the mitochondrial matrix), and plant Hsp101 are among the eukaryotic homologues of the bacterial ClpB. ClpB is a representative of the Hsp100 protein family that belongs to the AAA+ superfamily of ATPases (ATPases Associated with a variety of cellular Activities) [3] . For example, AAA+ ATPases are involved in assembling and disassembling of large protein complexes which are involved in cellular processes such as replication, recombination and DNA repair, intracellular transport and organelle biogenesis. They also play a key function in the posttranslational protein quality control system that takes care of the state of protein folding and the proper functioning of the cells. AAA+ proteins may have one (AAA-1) or two non-identical modules AAA (AAA-1, AAA-2; nucleotide binding domains). Each of them is composed of two subdomains: the N-terminal that is the core module and the C-terminal domain. The core consists of 200 -250 amino acid residues, which form a characteristic secondary structure conserved in the evolution, the α-β-α type [4, 5] . The core module contains two classical motifs, Walker A (GX 4 GKT/S) and Walker B (hy 4 DE), which are responsible for nucleotide binding and hydrolysis. In addition, the AAA module contains sensor-1 and sensor-2 motifs. These motifs are associated with the movement of AAA domains because they link ATP hydrolysis to conformational changes in the substrate binding domains of ClpB protein [6] . The C-terminal domain, located in the core of the AAA module, consists of at least three α-helices, and therefore is called the α-helix domain. Depending on the number of AAA modules, AAA+ ATPases can be divided into two classes. Class I includes proteins having both AAA-1 and AAA-2 modules (e.g. ClpA, ClpB/Hsp104). The AAA+ ATPases belonging to Class II contain only one AAA module, which corres-ponds to AAA-2 (e.g. ClpX, ClpY) [7] . AAA modules tend to oligomerize forming predominantly hexameric ring-shaped structures in which the individual subunits have the same orientation. Subunits of the hexameric ring can communicate with each other and react to conformational changes after nucleotide binding through α-helical domain interactions. Hexamers are the biologically active forms of AAA+ proteins. Bacterial ClpB protein contains all characteristic sequence motifs of AAA+ ATPases.
Structure, Function and Isoforms of the ClpB Chaperone
Like other Hsp100 proteins, ClpB forms barrel-shaped hexamers in the presence of ATP [8] . Each ClpB protomer is composed of an N-terminal domain, two ATPbinding modules (NBD-1, NBD-2 or AAA-1, AAA-2 modules), and an inserted coiled-coil middle domain (MD). Both NBD domains have been shown to bind and hydrolyze ATP. ATP binding to the NBD domaines stabilizes oligomeric structure of ClpB and its interaction with the protein substrates [9, 10] . ATP hydrolysis provides energy necessary for remodeling aggregated proteins. The most characteristic elements of the ClpB hexameric ring are a central channel and a long "coiledcoil" segment corresponding to MD located outside the hexamer. The unique MD with a length of about 120 amino acid residues distinguishes the ClpB protein from other Hsp100. It consists of two motifs: Motif 1 that contains helices 1, 2, and Motif 2 that is composed of helices 2, 3 and 4. Each of these motifs resembles a leucine zipper structure that is otherwise characteristic for the known eukaryotic transcription factors. However, unlike the classical leucine zipper motif, Motifs 1 and 2 present in the sructure of ClpB are composed of two anti-parallel α-helices with only three consecutive repeats of a leucine occurring every 7 amino acid residues [11] . It has been demonstrated that MD is a mobile element of ClpB. Its position and degree of mobility significantly affect this protein's chaperone activity and in turn the protein disaggregation and reactivation processes [11] . Removal of even a small fragment of MD destabilizes oligomeric states of ClpB and causes loss of its chaperone activity [12] . According to recent reports, MD (in particular Motif 1) mediates the interactions between subunits of ClpB, thus stabilizing the oligomeric structure of the protein; MD also links the ATPase activities of both NBD domains, especially in the presence of a protein substrate [13] . It has been also demonstrated that MD is essential for synergistic interaction with the system Hsp70/DnaK system, and it determines the species specificity of ClpB/Hsp104, required for cell suvival at high temperatures [14, 15] .
Recent finding on biological function of ClpB suggests that the unique chaperone activity of ClpB reversing aggregation is linked to translocation of protein substrates through the narrow central channel within the hexameric ring-shaped structure of ClpB [16] .
The ClpB chaperone from Escherichia coli (ClpB Ec ) as well as the yeast protein, Hsp104, have been the most intensely studied Hsp100 proteins in recent years because of their unique function in reactivation of protein aggregates formed under stress conditions. The clpB Ec gene contains an internal translation-initiation site and is expressed in vivo as two proteins: a full-length 95-kDa ClpB (ClpB95) and a N-terminal-truncated 80-kDa isoform (ClpB80, ClpB∆N) [17] (Figure 1) . The internal initiation site is located near the N-terminus of the first nuclotide-binding domain in ClpB. Thus, the N-terminal domain of ClpB95 is not present in ClpB80. The biological function of the N-terminal truncated isoform in reactivation of protein aggregates has been discovered relatively recently [18] . It was found that ClpB95 and ClpB80 cooperate in reactivation of proteins and form a highly efficient chaperone system. It is assumed that the functional cooperation between ClpB isoforms arises from interactions between them, because ClpB95 and ClpB80 associate into hetero-oligomers, which form with a higher efficiency than the homo-oligomers of ClpB95. Thus, it is very likely that the ClpB95/80 hetero-association boosts the aggregate-reactivation potential of ClpB and that E. coli produces two variants of ClpB to optimize its activity. The two isoforms of ClpB chaperone acting together also enhanced the solubility and enzymatic activity of β-galactosidase trapped in inclusion bodies [19] . This result supports an important role of synergistic cooperation between the two ClpB isoforms in aggregate reactivation.
The discovery of disaggregation activity of ClpB (Hsp104) chaperone revealed new therapeutic possibilities. For example it gave rise to new strategies in the treatment of neurodegenerative diseases. It was shown that the insoluble aggregates, which appear in neuronal cells and are associated with neurodegenerative diseases, con- tain, besides Hsp70 and Hsp40, such proteins as: VCP/ p97, torsin A and the 19S proteasomal complexes. These proteins belong to the AAA+ family of proteins similarly to ClpB. Currently, it is believed that chaperones play a protective role in neurodegenerative diseases. However, there may be another side of the chaperone function (chaperone-linked negative side effect). Namely, ClpB has been shown to be up-regulated in many pathogenic bacteria during infection of the host organism, which helps the pathogen to overcome host defenses.
ROLE OF THE CLPB MOLECULAR CHAPERONE IN PATHOGENIC BACTERIA-OTHER ASPECT OF ITS FUNCTION
The data accumulated over the last few years regarding several bacterial pathogens suggest that ClpB chaperone may play an important role in their virulence. However, currently it is not clear what specific role ClpB plays during bacterial infection. ClpB has been shown to be required for invasiveness and/or survival of many pathogens such as Mycoplasma pneumoniae, Porphyromonas gingivalis, Listeria monocytogenes, Mycobacterium tuberculosis, and Francisella tularensis [20] [21] [22] [23] [24] .
The clpB mutant of Leptospira interrogans has been also shown to be avirulent compared to its parental strains [25] . The loss of ClpB function in L. interrogans has also resulted in bacterial growth defects under oxidative and heat stresses. The authors demonstrated that the Leptospira ClpB is essential for survival under stress conditions and also during an in vivo infection. Pathogenic bacteria are exposed to a significant stress during infection of the host, frequently resulting in protein aggregation. The fact that ClpB is usually up-regulated in pathogens suggests that ClpB activity as a protein disaggregase may be important for their virulence. In the case of pathogens such as Mycoplasma pneumoniae and Francisella tularensis it has been also shown that ClpB elicits immune responsiveness in experimentally infected laboratory animals [20, 26] . Similarly, human sera collected from patients suffering from tularemia or infected with M. pneumoniae strongly recognized ClpB chaperone in contrast to uninfected controls. Our studies on the biolgical function of the ClpB from other pathogenic bacterium, Leptospira interrogans, and its potential role in pathogenesis of leptospirosis also suggest that ClpB of bacterial pathogens possesses an immunogenic potential. We have found that a Leptospira recombinant ClpB protein was recognized by sera collected from infected animals (unpublished data), and thus it is able to activate the host immune system. All of these results may indicate the involvement of ClpB function in the infection process. Sequence alignment of ClpB Ec and ClpB from some bacterial pathogens using the Clustal software shows that ClpB proteins of pathogenic bacteria have a similar domain organization to that of ClpB Ec with all charasteristic AAA+ motifs (Walker A, Walker B, sensor-1, sensor-2). For example, the total sequence identity between ClpB Ec and the Leptospira interrogans ClpB is 52% (27.7% within ND, 45.3% within MD, 72% within NBD-1, and 65.7% within NBD-2). Similarity with orthologs from the pathogen L. borgpetersenii and the saprophyte L. biflexa is 95% and 62%, respectively [25] . It is tempting to speculate that the low sequence similarity between Leptospira interrogans ClpB and ClpB from the saprophytic species, L. biflexa, indicates the presence of a yet unknown element in this protein, that can determine ClpB's virulent properties. It would be intriguing to compare in greater detail the biochemical properties of ClpB proteins from the pathogenic and saprophytic species of Leptospira.
To date, there is only one published report on detailed biochemical studies of ClpB activity isolated from a pathogenic bacterium [27] . These studies were done by Prof. Zolkiewski's group with Ehrlichia chaffeensis ClpB and show that there are several differences between species in the functioning of ClpB proteins. It was found that the basal ATPase activity of Ehrlichia chaffeensis ClpB was similar to that of the ClpB Ec . However, while the ATPase of ClpB Ec was activated in the presence of casein or poly-lysine, the ATPase of ClpB from Ehrlichia did not respond to the activators. Moreover, it was demonstrated that: 1) Ehrlichia ClpB can reactivate some aggregated substrates even in the absence of the DnaK system, while ClpB Ec requires the co-chaperones to disaggregate a substrate; 2) the ClpB from Ehrlichia does not rescue the growth-defect of the clpB-null E. coli under heat-shock. Thus Ehrlichia ClpB can not function in the E. coli cells and substitute for ClpB Ec . A lack of complementation effect may confirm species-specificity of ClpB proteins and suggests that the substrates recognized by ClpB of pathogens during infection of the host differ from the proteins aggregated upon heat shock in E. coli cells. Such result could prove functional differences between the ClpB proteins from pathogenic bacteria and E. coli. Futher studies are needed to clarify the role of ClpB chaperone as a virulence factor in bacterial infectious diseases. It is worth to note that ClpB is not the only chaperone involved in virulence of pathogenic bacteria. For example, synthesis of two other major chaperones, DnaK and GroESL from Staphylococcus aureus, has been shown to be induced during infection of human epithelial cells [28] ; also DnaK from Listeria monocytogenes is required for survival under stress conditions and efficient phagocytosis with macrophages [29] . Similarly, the highly conserved ClpB family has been demonstrated to play an important role in the virulence of many pathogenic bacteria. The ClpC and ClpXP from Porphyromonas gingivalis have been found to be essential for survival under heat shock and during entry into host epithelial cells [21] . All of these data suggest that molecular chaperones play importat roles in invasion and virulence of bacterial pathogens, as 1) they help the pathogen to overcome stressfull conditions to which it is exposed within the host cells, and 2) they represent major targets of the host's immune system.
Since it is known that ClpB does not exist in mammals, and taking into account its potential role in virulence, it is reasonable to consider it as a potential therapeutic target in antibacterial therapies. Thus, ClpB offers new hope in the fight against pathogenic bacteria. Understanding the function of ClpB in pathogens and dissecting its biochemical properties may improve the development of treatment of several major bacterial diseases, particularly those which do not respond to conventional antibiotics. For treatment of diseases caused by pathogenic bacteria, interfering with the function of the clpB gene could provide a new direction in antimicrobial therapies as taking ClpB as a therapeutic target could be more successful than using currently available antibiotics. Therefore, studies on the biological role and biochemical mechanism of ClpB in pathogens are so important and should be continued to demonstrate if ClpB is in fact important during infection due to its role as molecular chaperone taking part in reactivation of protein aggregates.
